Odaily Planet Daily News: According to data from MSX.COM, drug development company Sellas Life Sciences surged 220% at opening, after the company announced on Tuesday that its experimental vaccine for a blood cancer showed positive results in a late-stage clinical trial, significantly extending patients' survival time.
Sellas Life Sciences shares surged 220% at market opening
2026-11-17 14:42:02
Share
Disclaimer: This article is copyrighted by the original author and does not represent MyToken’s views and positions. If you have any questions regarding content or copyright, please contact us.(www.mytokencap.com)contact
About MyToken:https://www.mytokencap.com/en/aboutusArticle Link:https://www.mytokencap.com/en/choicenews/3662799
More exciting content is available on
X(https://x.com/MyTokencap)or join the community to learn more:MyToken-English Telegram Group
(https://t.me/mytokenGroup)
X(https://x.com/MyTokencap)or join the community to learn more:MyToken-English Telegram Group
(https://t.me/mytokenGroup)